Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-32,500
Closed -$5.62M – 583
2024
Q2
$5.62M Buy
+32,500
New +$5.65M 0.19% 62
2023
Q3
– Sell
-25,000
Closed -$3.35M – 505
2023
Q2
$3.35M Buy
+25,000
New +$3.23M 0.49% 26
2022
Q2
– Sell
-5,672
Closed -$737K – 638
2022
Q1
$737K Sell
5,672
-829
-13% -$108K 0.06% 157
2021
Q4
$869K Buy
+6,501
New +$815K 0.09% 139
2020
Q1
– Sell
-6,277
Closed -$804K – 484
2019
Q4
$804K Buy
+6,277
New +$816K 0.11% 113
2019
Q1
– Sell
-3,893
Closed -$423K – 437
2018
Q4
$423K Buy
+3,893
New +$467K 0.07% 131
2018
Q1
– Sell
-8,637
Closed -$1.27M – 374
2017
Q4
$1.27M Buy
8,637
+4,244
+97% +$617K 0.06% 178
2017
Q3
$609K Hold
4,393
– – 0.02% 268
2017
Q2
$646K Buy
4,393
+837
+24% +$126K 0.02% 241
2017
Q1
$592K Buy
+3,556
New +$596K ﹤0.01% 209

Other funds holding IBM

Caxton Associates (New York)'s IBM Position: Q3 2024 in Review

Caxton Associates (New York) sold out of IBM (IBM) in Q3 2024, closing a stake of 32,500 shares — an estimated $5.62M sold.

Caxton Associates (New York) first reported a position in IBM in Q1 2017 and held it in 10 quarters. The position peaked at $5.62M in Q2 2024. 2,936 funds tracked by Wall St. Rank hold IBM as of Q3 2024.

  • Caxton Associates (New York) reported no remaining IBM position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 32,500 IBM shares in Q3 2024, an estimated $5.62M.
  • Caxton Associates (New York) first reported a position in IBM in Q1 2017 and held it in 10 quarters.
  • Caxton Associates (New York)'s IBM position peaked at $5.62M in Q2 2024.
  • 2,936 funds tracked by Wall St. Rank held IBM as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.